“…[4][5][6][7][8] However, obtaining ligands for "difficult" targetse.g., protein-protein interactionsmay remain challenging when using Lipinski's rule of ve compliant single-pharmacophore DELs, displaying typically compounds consisting of two or three sets of diversity elements. [9][10][11][12] While some approaches are currently explored to create better performing single-pharmacophore DELs, for example by developing new DNA-compatible reactions, [13][14][15] adopting diverse scaffolds and building blocks, [16][17][18] or exploring different spatial building block arrangements, 10,19,20 another promising option to tackle difficult targets may be exploring larger binding surfaces. 21 This has been attempted, for instance, by generating macrocyclic DELs, 16,[22][23][24][25] but large libraries in general will require the introduction of several sets of building blocks, thereby lowering DEL library quality.…”